Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings.

Autor:	Tanaka, Nobuyuki1,2 urotanaka@gmail.com, Mizuno, Ryuichi1 mizunor@z7.keio.jp, Shirotake, Suguru3, Ito, Keiichi4, Yasumizu, Yota3, Masunaga, Ayako4, Ito, Yujiro5, Miyazaki, Yasumasa1, Hagiwara, Masayuki6, Kanao, Kent7, Mikami, Shuji8, Nakagawa, Ken6, Momma, Tetsuo9, Masuda, Takeshi2, Asano, Tomohiko4, Oyama, Masafumi3, Oya, Mototsugu1
Zdroj:	Urologic Oncology. Jul2016, Vol. 34 Issue 7, p293.e17-293.e25. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect